In 2025, Livzon Pharmaceutical Group conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 94,640.8a | 103,155.7a | 106,199.5a | |
Total Waste Recovered | 31,020.1a | 33,684.6a | 47,684.9a | |
Total Hazardous Waste Generated | 12,902.9a | 2,791a | 2,708.2a | |
Non-Hazardous Waste Disposed | 51,822.7a | 67,226.3a | 56,229.3a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Livzon Pharmaceutical Group generated a total of 94,641metric tonnes of waste.a
Of this amount, 32.78% of Livzon Pharmaceutical Group's total waste generated was recovered through methods such as recycling, reuse, or composting, while 67.22% was disposed of through landfilling, incineration, or combustion.a
In 2025, Livzon Pharmaceutical Group reported a total waste generation of 94,641 metric tonnes, of which 32.78% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Livzon Pharmaceutical Group is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2023, Livzon Pharmaceutical Group's total waste generation decreased by 10.88%, including a further 8.25% drop in 2025, highlighting a consistent and deliberate reduction in waste production over time.a
Over the same period, Livzon Pharmaceutical Group's waste recovery rate declined by 27%, and then remained stable in 2025, possibly indicating that earlier setbacks have leveled off without signs of active improvement.a
Overall, Livzon Pharmaceutical Group’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
In 2025, Livzon Pharmaceutical Group generated a total of 94,641 metric tonnes of waste.a
Of this amount, 13.63% of Livzon Pharmaceutical Group's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.86.37% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2023, Livzon Pharmaceutical Group's total waste generation decreased by 10.88%, with an additional 8.25% decline in 2025, suggesting a consistent and deliberate effort to minimize waste generation at the source.a
Over the same period, the share of hazardous waste in Livzon Pharmaceutical Group's total output increased by 434.63%, including a further 403.9% rise in 2025, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.a
Overall, Livzon Pharmaceutical Group's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2025, Livzon Pharmaceutical Group reported that 12,903 metric tonnes of its total waste output were classified as hazardous. This represents 13.63% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Only 8.56% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with Livzon Pharmaceutical Group’s current hazardous waste practices.a